It is found that the combination of soybean lecithin and a non steroidal anti-inflammatory drug has anticancer effect

Colorectal cancer is the third leading cause of cancer deaths in the United States, with 50630 deaths expected this year When scientists from the University of Texas Health (http:// Medical Center (uthealth) applied soy lecithin with a non steroidal anti-inflammatory drug (NSAID), they found that it had increased anticancer activity and reduced side effects The researchers compared the combination of nonsteroidal anti-inflammatory drug indomethacin and soybean lecithin with three other NSAIDs, one of which is aspirin The results showed that the combination of the two drugs provided better anti colorectal cancer effect and reduced gastrointestinal bleeding The study was a preclinical trial on a mouse model (http:// NSAIDs work by reducing the production of a substance that promotes inflammation, pain and fever They are used to prevent heart disease and reduce arthritis pain, and they can also be used to prevent colorectal cancer However, NSAIDs can also cause problems if taken for months or years in a row, the researchers said For non aspirin NSAIDs like indomethacin, the damage to the gut is more severe than gastric ulcer This is their latest preclinical trial on soybean lecithin to reduce side effects caused by NSAIDs and have potential anticancer effects.